Reactive oxygen species play a critical role in collagen-induced platelet activation via shp-2 oxidation

Antioxidants and Redox Signaling

Volumn 20, Issue 16, 2014, Pages 2528-2540

  Jang, Ji Yong ^a   Min, Ji Hyun ^a   Chae, Yun Hee ^a   Baek, Jin Young ^a   Wang, Su Bin ^a   Park, Su Jin ^a   Oh, Goo Taeg ^a   Lee, Sang Hak ^b   Ho, Ye Shih ^c   Chang, Tong Shin ^a  

^a Ewha Womans University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CATALASE; COLLAGEN; GLUTATHIONE PEROXIDASE 1; LAT PROTEIN; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE SHP 2; PROTEIN VAV1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VAV PROTEIN; PTPN11 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CAROTID ARTERY INJURY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; KNOCKOUT MOUSE; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; COLLAGEN; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATION-REDUCTION; PLATELET ACTIVATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; REACTIVE OXYGEN SPECIES;

EID: 84900387922     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5337     Document Type: Article

References (59)

1. Allen J. Photoplethysmography and its application in clinical physiological measurement. Physiol Meas 28: R1-R39, 2007.
2. Arias-Salgado EG, Haj F, Dubois C, Moran B, Kasirer-Friede A, Furie BC, Furie B, Neel BG, and Shattil SJ. PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol 170: 837-845, 2005.
3. Atkinson BT, Ellmeier W, and Watson SP. Tec regulates platelet activation by GPVI in the absence of Btk. Blood 102: 3592-3599, 2003.
4. Bakdash N and Williams MS. Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic Biol Med 45: 158-166, 2008.
5. Barford D and Neel BG. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phos-phatase SHP-2. Structure 6: 249-254, 1998.
6. Barrett WC, DeGnore JP, Keng YF, Zhang ZY, Yim MB, and Chock PB. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J Biol Chem 274: 34543-34546, 1999.
7. Begonja AJ, Gambaryan S, Geiger J, Aktas B, Pozgajova M, Nieswandt B, and Walter U. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 106: 2757-2760, 2005.
8. Blanchetot C, Chagnon M, Dube N, Halle M, and Tremblay ML. Substrate-trapping techniques in the identification of cellular PTP targets. Methods 35: 44-53, 2005.
9. Buczynski A, Wachowicz B, Kedziora-Kornatowska K, Tkaczewski W, and Kedziora J. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 100: 223-228, 1993.
10. Chari R, Kim S, Murugappan S, Sanjay A, Daniel JL, and Kunapuli SP. Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion. Blood 114: 3056-3063, 2009.
11. Chen J, Diacovo TG, Grenache DG, Santoro SA, and Zutter MM. The alpha(2) integrin subunit-deficient mouse: a mul-tifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 161: 337-344, 2002.
12. D'Autreaux B and Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeo-stasis. Nat Rev Mol Cell Biol 8: 813-824, 2007.
13. Del Principe D, Menichelli A, De Matteis W, Di Corpo ML, Di Giulio S, and Finazzi-Agro A. Hydrogen peroxide has a role in the aggregation of human platelets. FEBS Lett 185: 142-146, 1985.
14. Dustin LB, Plas DR, Wong J, Hu YT, Soto C, Chan AC, and Thomas ML. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. J Immunol 162: 2717-2724, 1999.
15. Farrehi PM, Ozaki CK, Carmeliet P, and Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 97: 1002-1008, 1998.
16. Flint AJ, Tiganis T, Barford D, and Tonks NK. Development of ''substrate-trapping'' mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci U S A 94: 1680-1685, 1997.
17. Frearson JA and Alexander DR. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. J Exp Med 187: 1417-1426, 1998.
18. Fujii C, Yanagi S, Sada K, Nagai K, Taniguchi T, and Ya-mamura H. Involvement of protein-tyrosine kinase p72syk in collagen-induced signal transduction in platelets. Eur J Biochem 226: 243-248, 1994.
19. Furlong MT, Mahrenholz AM, Kim KH, Ashendel CL, Harrison ML, and Geahlen RL. Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk. Biochim Biophys Acta 1355: 177-190, 1997.
20. Ganju RK, Brubaker SA, Chernock RD, Avraham S, and Groopman JE. Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem 275: 17263-17268, 2000.
21. Goodall AH and Appleby J. Flow-cytometry analysis of platelet-membrane glycoprotein expression and platelet activation. In: Platelets and Megakaryocytes. edited by Gibbins JM and Mahaut-Smith MP. Totowa, NJ: Humana Press, 2004, p. 233.
22. Ho YS, Magnenat JL, Bronson RT, Cao J, Gargano M, Sugawara M, and Funk CD. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272: 16644-16651, 1997.
23. Ho YS, Xiong Y, Ma W, Spector A, and Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279: 32804-32812, 2004.
24. Hughes CE, Auger JM, McGlade J, Eble JA, Pearce AC, and Watson SP. Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2. J Thromb Haemost 6: 2152-2159, 2008.
25. Jackson SP, Schoenwaelder SM, Yuan Y, Salem HH, and Co-oray P. Non-receptor protein tyrosine kinases and phospha-tases in human platelets. Thromb Haemost 76: 640-650, 1996.
26. Jandrot-Perrus M, Lagrue AH, Okuma M, and Bon C. Adhesion and activation of human platelets induced by con-vulxin involve glycoprotein VI and integrin alpha2beta1. J Biol Chem 272: 27035-27041, 1997.
27. Johnson RM, Ho YS, Yu DY, Kuypers FA, Ravindranath Y, and Goyette GW. The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med 48: 519-525, 2010.
28. Jones KL, Hughan SC, Dopheide SM, Farndale RW, Jackson SP, and Jackson DE. Platelet endothelial cell adhesion mol-ecule-1 is a negative regulator of platelet-collagen interactions. Blood 98: 1456-1463, 2001.
29. Karisch R, Fernandez M, Taylor P, Virtanen C, St-Germain JR, Jin LL, Harris IS, Mori J, Mak TW, Senis YA, Ostman A, Moran MF, and Neel BG. Global proteomic assessment of the classical protein-tyrosine phosphatome and ''Re-doxome''. Cell 146: 826-840, 2011.
30. Krotz F, Sohn HY, Gloe T, Zahler S, Riexinger T, Schiele TM, Becker BF, Theisen K, Klauss V, and Pohl U. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100: 917-924, 2002.
31. Kuchay SM, Kim N, Grunz EA, Fay WP, and Chishti AH. Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets. Mol Cell Biol 27: 6038-6052, 2007.
32. Kwon J, Qu CK, Maeng JS, Falahati R, Lee C, and Williams MS. Receptor-stimulated oxidation of SHP-2 promotes T-cell adhesion through SLP-76-ADAP. EMBO J 24: 2331-2341, 2005.
33. Lee FA, van Lier M, Relou IA, Foley L, Akkerman JW, Heijnen HF, and Farndale RW. Lipid rafts facilitate the interaction of PECAM-1 with the glycoprotein VI-FcR gamma-chain complex in human platelets. J Biol Chem 281: 39330-39338, 2006.
34. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inacti-vation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
35. Maeda A, Scharenberg AM, Tsukada S, Bolen JB, Kinet JP, and Kurosaki T. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene 18: 2291-2297, 1999.
36. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
37. Mancini F, Rigacci S, Berti A, Balduini C, and Torti M. The low-molecular-weight phosphotyrosine phosphatase is a negative regulator of FcgammaRIIA-mediated cell activation. Blood 110: 1871-1878, 2007.
38. Meng TC, Fukada T, and Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399, 2002.
39. Ming Z, Hu Y, Xiang J, Polewski P, Newman PJ, and Newman DK. Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation. Blood 117: 3903-3906, 2011.
40. Monteiro HP, Arai RJ, and Travassos LR. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antioxid Redox Signal 10: 843-889, 2008.
41. Moraes LA, Barrett NE, Jones CI, Holbrook LM, Spyridon M, Sage T, Newman DK, and Gibbins JM. Platelet endothe-lial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phospha-tidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells. J Thromb Haemost 8: 2530-2541, 2010.
42. Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, Wang Y, Shaw JA, Levine RL, Ni H, Tall AR, and Wang N. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat Med 19: 586-594, 2013.
43. Nieswandt B and Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 102: 449-461, 2003.
44. Pasquet JM, Gross B, Quek L, Asazuma N, Zhang W, Sommers CL, Schweighoffer E, Tybulewicz V, Judd B, Lee JR, Koretzky G, Love PE, Samelson LE, and Watson SP. LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI. Mol Cell Biol 19: 8326-8334, 1999.
45. Pasquet JM, Quek L, Pasquet S, Poole A, Matthews JR, Lowell C, and Watson SP. Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI. J Biol Chem 275: 28526-28531, 2000.
46. Patil S, Newman DK, and Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 97: 1727-1732, 2001.
47. Pearce AC, Wilde JI, Doody GM, Best D, Inoue O, Vigorito E, Tybulewicz VL, Turner M, and Watson SP. Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phos-pholipase C. Blood 100: 3561-3569, 2002.
48. Persson C, Sjoblom T, Groen A, Kappert K, Engstrom U, Hellman U, Heldin CH, den Hertog J, and Ostman A. Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A 101: 1886-1891, 2004.
49. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, and Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 91: 484-490, 1998.
50. 2, a necessary evil for cell signaling. Science 312: 1882-1883, 2006.
51. Salmeen A and Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 7: 560-577, 2005.
52. Singh DK, Kumar D, Siddiqui Z, Basu SK, Kumar V, and Rao KV. The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. Cell 121: 281-293, 2005.
53. Stone JR and Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8: 243-270, 2006.
54. Suzuki-Inoue K, Wilde JI, Andrews RK, Auger JM, Siraganian RP, Sekiya F, Rhee SG, and Watson SP. Glyco-proteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites. Biochem J 378: 1023-1029, 2004.
55. Tonks NK and Neel BG. From form to function: signaling by protein tyrosine phosphatases. Cell 87: 365-368, 1996.
56. Watson SP, Auger JM, McCarty OJ, and Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 3: 1752-1762, 2005.
57. Weibrecht I, Böhmer S-A, Dagnell M, Kappert K, Ostman A, and Böhmer F-D. Oxidation sensitivity of the catalytic cys-teine of the protein-tyrosine phosphatases SHP-1 and SHP-2. Free Radic Biol Med 43: 100-110, 2007.
58. Weng Z, Li D, Zhang L, Chen J, Ruan C, Chen G, Gartner TK, and Liu J. PTEN regulates collagen-induced platelet activation. Blood 116: 2579-2581, 2010.
59. Yamagishi SI, Edelstein D, Du XL, and Brownlee M. Hy-perglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 50: 1491-1494, 2001.